Quality Investor

Intrepid Potash, Inc.

Rank #454Op. Leverage

IPI · NYSE · Basic Materials

Intrepid Potash, Inc. (IPI) — Rank #454 by gross profitability (GP/assets 0.08) · ROE 2.2% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0001421461 · all metrics point-in-time as of the filing date.

About

Intrepid Potash, Inc. delivers potassium, magnesium, sulfur, salt, and water products.

Show more

It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as in agricultural market as a fertilizer input, in animal feed market as a nutrient supplement, in industrial market as a component in drilling and fracturing fluids, as well as input to other industrial processes. It also provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle; salt for various markets, including animal feed, industrial applications, pool salt, and the treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use as a road treatment agent for deicing and dedusting; brines for use in oil and gas industry to support well workover and completion activities; and metal recovery salts.

The company was founded in 2000 and is based in Denver, Colorado.

Industry
Agricultural Inputs
Sector
Basic Materials
State
DE
Filer Category
Accelerated filer
Fiscal Year End
December 31

Price History

IPI+27.9% · +5.0% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$518.18M

P/E (annual)

45.3

P/S (annual)

1.7

P/B

1.0

P/OCF (annual)

9.3

Shareholder Yield

-2.3%

Employees

478

Industry

Agricultural Inputs

Exchange

NYSE

Signal Flags

2 green1 yellow
Revenue growth acceleratingGrowth rate increasing year over year
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 1-quarter streak
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation

Quality Profile

Profitability

1/1 pass
GP / assets
0.08
Return on equity
2.2%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.26
Current ratio
6.33×
Net cash
$185.16M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.7%

Growth

1/2 pass
Revenue growth
17.1%
Piotroski F-Score
N/A
Share dilution
2.3%

Terry Smith quality gate

Passes 2/5 Terry Smith thresholds

What Growth Is Priced In

Implied revenue growth (10Y)

7.6%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 2.3% — per-share value needs a total required return of 9.9% once share-count change is priced in.

vs. own 6-year median revenue growth: 17.1%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

3.3%

r = 10% (base)

7.6%

r = 12%

11.3%

Net debt / market cap: -36.5%

Base FCF: $25.5M3Y mean FCF: $25.5M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / S

Price / revenue per share

1.8xCheap
1.8xmed 1.8x2.0x

P / B

Price / book value per share

1.1xFair
0.7xmed 1.1x1.1x

P / GP

Price / gross profit per share

9.6xCheap
9.6xmed 13.8x17.7x

Operating margin expansion and free cash flow are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.08

Primary signal (Novy-Marx).

6th of 6 SIC 1400 peers

Return on equity

2.2%

Gross margin

18.4%

6th of 6 SIC 1400 peers

Revenue growth (YoY)

17.1%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.26

4th of 6 SIC 1400 peers (best = lowest)

Current ratio

6.33×

2nd of 6 SIC 1400 peers

Quick ratio

4.12×

Net cash

$185.16M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$25.54M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

1.28

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.7%

Stock-based comp intensity.

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

Lifecycle Phase History

20232025
Op. Leverage